IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORUCCI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.218
EU - Europa 12.126
AS - Asia 11.484
SA - Sud America 2.132
AF - Africa 311
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 16
Totale 43.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.782
SG - Singapore 5.747
IE - Irlanda 2.053
UA - Ucraina 2.035
RU - Federazione Russa 1.763
BR - Brasile 1.669
CN - Cina 1.482
SE - Svezia 1.482
IT - Italia 1.468
HK - Hong Kong 1.273
VN - Vietnam 1.078
DE - Germania 772
FR - Francia 768
FI - Finlandia 659
GB - Regno Unito 412
KR - Corea 368
IN - India 258
TR - Turchia 240
CA - Canada 222
BD - Bangladesh 221
AR - Argentina 142
IQ - Iraq 135
MX - Messico 125
PL - Polonia 116
AT - Austria 100
ZA - Sudafrica 97
CH - Svizzera 92
PK - Pakistan 88
NL - Olanda 84
JP - Giappone 78
UZ - Uzbekistan 73
CO - Colombia 72
EC - Ecuador 72
ID - Indonesia 72
ES - Italia 69
VE - Venezuela 69
SA - Arabia Saudita 62
PH - Filippine 50
MA - Marocco 46
BE - Belgio 44
EE - Estonia 39
LB - Libano 35
CZ - Repubblica Ceca 34
PY - Paraguay 33
GR - Grecia 30
KE - Kenya 30
MY - Malesia 29
CL - Cile 25
RO - Romania 25
TN - Tunisia 25
AE - Emirati Arabi Uniti 23
EG - Egitto 23
JM - Giamaica 20
PE - Perù 20
LT - Lituania 18
UY - Uruguay 18
ET - Etiopia 17
KZ - Kazakistan 17
EU - Europa 15
JO - Giordania 15
AZ - Azerbaigian 14
LY - Libia 13
OM - Oman 13
IL - Israele 12
NP - Nepal 12
PA - Panama 12
TH - Thailandia 12
CR - Costa Rica 11
DZ - Algeria 11
AU - Australia 10
BO - Bolivia 10
RS - Serbia 10
KG - Kirghizistan 9
PS - Palestinian Territory 9
AL - Albania 8
BG - Bulgaria 8
CI - Costa d'Avorio 8
DO - Repubblica Dominicana 8
HN - Honduras 7
SN - Senegal 7
TW - Taiwan 7
GE - Georgia 6
KW - Kuwait 6
AM - Armenia 5
BB - Barbados 5
BN - Brunei Darussalam 5
GT - Guatemala 5
HR - Croazia 5
IR - Iran 5
NG - Nigeria 5
DK - Danimarca 4
GA - Gabon 4
HU - Ungheria 4
NO - Norvegia 4
PT - Portogallo 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TJ - Tagikistan 4
AO - Angola 3
BF - Burkina Faso 3
Totale 43.225
Salva come PNG Salva come JPEG
Città #
Singapore 4.128
Chandler 2.286
Dublin 2.044
San Jose 1.579
Hong Kong 1.272
San Mateo 1.228
Ashburn 1.072
Jacksonville 841
Boardman 744
Santa Clara 693
Moscow 634
Dong Ket 622
Medford 548
Princeton 542
Altamura 518
Wilmington 499
Lauterbourg 495
Lawrence 383
Andover 345
Ann Arbor 341
Perugia 325
Beijing 322
Des Moines 318
Seoul 291
Los Angeles 227
New York 198
The Dalles 186
São Paulo 170
Saint Petersburg 165
Ho Chi Minh City 150
Helsinki 131
Izmir 120
Munich 117
Piscataway 107
Hanoi 99
Norwalk 96
Falls Church 95
Ottawa 85
Columbus 78
Brooklyn 76
Orem 74
Shanghai 73
Warsaw 72
Tokyo 70
Dallas 69
Woodbridge 64
Baghdad 62
Rio de Janeiro 57
San Paolo di Civitate 57
Frankfurt am Main 56
Houston 54
Johannesburg 54
Montreal 52
Chennai 51
Council Bluffs 50
Chicago 47
Nuremberg 46
Stockholm 46
Turku 46
Brussels 43
London 43
Manchester 38
Vienna 38
Amsterdam 37
Mexico City 37
Tashkent 37
Toronto 37
Redwood City 35
Phoenix 34
Curitiba 33
Redmond 33
Rome 33
Boston 32
Dhaka 30
Ankara 29
Denver 29
San Francisco 29
Lahore 28
Quito 28
Seattle 28
Poplar 27
Atlanta 26
Belo Horizonte 26
Milan 26
Auburn Hills 25
Den Haag 25
Dearborn 24
Brasília 23
Guayaquil 23
New Delhi 23
Jeddah 22
Nairobi 22
Buffalo 21
Da Nang 21
Hefei 21
Naples 21
Porto Alegre 21
Riyadh 21
Istanbul 20
Medellín 20
Totale 26.439
Salva come PNG Salva come JPEG
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 190
Il reflusso entero-gastrico:quale ruolo nella patogenesi dell' esofagite 164
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 147
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 147
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 146
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 142
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 141
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 141
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 138
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. 137
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 135
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 135
A farnesoid X receptor-small heterodimer partner regulatory cascade modulates tissue metallproteinase inhibitor-1 and matrix metallprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis’ 133
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 133
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 132
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 130
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 129
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 128
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 128
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritis 127
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 127
Cancro gastrico localmente avanzato. Dati preliminari di studio di fase II di chemioterapia neoadiuvante, chirurgia radicale e chemioterapia adiuvante ad alte dosi con autotrapianto di cellule staminali da sangue periferico. 126
A new protective mechanisn in NSAID gastropathy. Evidence that hydrogen sulfide (H2S) modulates gastric mucosal integrity 125
Bombesin-Induced Pancreatic Regeneration in pigs in associated with p46Shc/p52Shc and p42/p44 MAP kinase Phosphorilation 125
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 125
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 123
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 122
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 122
Isolated guinea pig gastric chief cells express tumor necrosis factor receptors coupled with the sphingomyelin pathway 120
Effect of bombesin on pancreatic regeneration after subtotal distal pancreasectomy. 120
Antiatherosclerotic effect of farnesoid X receptor. 120
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 120
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 119
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 118
Cooperation between Aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. 117
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 117
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 117
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 116
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 116
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 114
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 114
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 114
Effect of acute and chronic levosulpiride administration on gastric tone and perception in functional dyspepsia. 113
Essential counter-regulatory role of farnesoid-X-receptor (FXR) for intestinal innate immunity 113
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 113
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 112
Prostaglandin-e2 Desensitizes Camp-mediated Pepsinogen Secretion In Chief Cells 111
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 110
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 110
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. 109
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 109
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. 109
A magic bullet for mucosal protection...and aspirin is the trigger! 109
PAR-2 modulates pepsinogen secretion from gastric-isolated chief cells. 107
Epigenetic Modulation of Adhesion and Proliferation Pathways by Methionine Deficiency Attenuates Potential for Dissemination of Gastric Cancer Cells 107
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 106
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 106
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 106
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 106
Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders 106
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 105
Interactions Between Nuclear Receptor SHP and FOXA1 Maintain Oscillatory Homocysteine Homeostasis in Mice 105
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 104
Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. 104
D-2-antagonist levosulpiride inhibits afferent mediating perception of gastric distention in functional dyspepsia. 104
Abscess Formation In Hepatocellular-carcinoma - Complications of Percutaneous Ultrasound-guided Ethanol Injection 104
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 104
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 104
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 104
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 103
5-hydroxytryptamine 3-receptor Antagonist Modulates Gallbladder Emptying and Motilin Release Induced By Erythromycin 103
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 103
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 103
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 103
Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents 102
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 102
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats 102
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 102
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis 101
Alkaline esophageal reflux- A misnomer 101
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 101
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies 101
Nitric oxide regulates immune cell bioenergetic: a mechanism to understand immunomodulatory functions of nitric oxide-releasing anti-inflammatory drugs. 100
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 100
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 100
Epidermal growth factor modulates pepsinogen secretion in guinea pig gastric chief cells 100
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 100
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 100
Nitric oxide modulates pepsinogen secretion induced by calcium-mediated agonist in guinea pig gastric chief cells. 99
.The vagal control of gallbladder motility is impaired in diabetics with autonomic neuropathy. 99
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 99
Bile Acid Signaling in Inflammatory Bowel Diseases 99
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy. A Review. 98
Primary brain abscess with Nocardia farcinica in an immunocompetent patient 98
Leukotrienes stimulate pepsinogen secretion from guinea pig gastric chief cells by a nitric oxide-dependent pathway 97
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 97
Endothelial nitric oxide synthase: the Cinderella of inflammation? 97
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 97
Nitric oxide-releasing NSAIDs: a review of their current status. 96
Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis. 96
Totale 11.439
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.970
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021718 0 0 0 0 0 0 0 0 0 0 0 718
2021/20224.328 96 816 68 233 106 173 57 1.466 52 93 389 779
2022/20237.812 605 1.266 68 617 658 992 2 433 2.807 14 243 107
2023/20242.407 206 312 144 50 35 21 464 146 162 94 412 361
2024/20256.875 69 695 224 227 902 284 247 602 1.423 456 1.066 680
2025/202614.464 1.059 898 860 1.698 1.799 1.247 2.610 769 1.709 1.233 407 175
Totale 44.191